Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli

Alifia Risma Fahmi, Suharjono, Kuntaman

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Escherichia coli is one of the pathogenic bacteria that caused a nosocomial infection. Levofloxacin is one of the fluoroquinolones group antibiotics which is a broad-spectrum antibiotic that works effectively against E. coli. The mutation can happen in the bacteria which caused a resistant effect in the use of antibacterial. This study aimed at identifying mutation in gene gyrA among E. coli that were resistant to levofloxacin. The susceptibility of E. coli was determined by disk diffusion. PCR and sequencing were performed to identify the mutation in gyrA. A total of 10 isolates showed result resistance to levofloxacin and gyrA gene mutation in the amino acid changes. Nucleotide sequence analysis revealed a point mutation in QRDR (quinolone resistance determining region) of gyrA Ser83→Leu, Asp87→Asn. The silent mutation was also found at codon Val85, Arg91, Ser111, Thr123. Mutation in the gyrA gene affect the occurrence of bacterial resistance of E. coli to levofloxacin.

Original languageEnglish
Pages (from-to)751-754
Number of pages4
JournalJournal of Basic and Clinical Physiology and Pharmacology
Volume32
Issue number4
DOIs
Publication statusPublished - 1 Jul 2021

Keywords

  • Escherichia coli
  • codon
  • gyrA
  • levofloxacin
  • mutation

Fingerprint

Dive into the research topics of 'Profile of gyrA gene mutation in clinical isolate of levofloxacin resistant Escherichia coli'. Together they form a unique fingerprint.

Cite this